Edesa Biotech, Inc. is a biopharmaceutical company, which focuses on acquiring, developing, and commercializing clinical stage drugs for inflammatory and immune-related diseases. Its clinical studies include EB05 for Acute Respiratory Distress Syndrome (ARDS), EB07 for systemic sclerosis (SSc), EB01 for chronic Allergic Contact Dermatitis (ACD), EB02 for hemorrhoids, and EB06 for vitiligo. The company was founded by Dr. Pardeep Nijhawan on June 12, 2007 and is headquartered in Markham, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
16
Frequently Asked Questions
What is Market Cap of Edesa Biotech Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Edesa Biotech Inc market cap is $16.82M.
What is the 52-week high for Edesa Biotech Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Edesa Biotech Inc 52 week high is $5.00 as of September 19, 2025.
What is the 52-week low for Edesa Biotech Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Edesa Biotech Inc 52 week low is $1.55 as of September 19, 2025.
What is Edesa Biotech Inc stock price today?
Edesa Biotech Inc stock price today is $2.30.
What was Edesa Biotech Inc stock price yesterday?
Edesa Biotech Inc stock price yesterday was $2.39.
What is the PE ratio of Edesa Biotech Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Edesa Biotech Inc’s P/E ratio is -1.80.
What is the Price-to-Book ratio of Edesa Biotech Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Edesa Biotech Inc P/B ratio is 3.4188.
What is the 50-day moving average of Edesa Biotech Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Edesa Biotech Inc 50-day moving average is $2.32.
